The efficacy of liraglutide-based drugs on the model of induced metabolic syndrome in experimental animals

The efficacy of liraglutide-based drugs on the model of induced metabolic syndrome in experimental animals

Today, there is an annualincrease in the prevalence of obesityandoverweightworldwide.Thisproblem is becomingparticularlyrelevant,sincetheseconditionsserve as keyriskfactors for the development of anumber of cardiovascularandmetabolicdisorders,including type 2diabetesmellitus(T2DM).On the territory o...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Andreev-Andrievsky, M. A. Mashkin, M. Vannous, O. V. Fadeeva, Yu. G. Kazaishvili, D. V. Kurkin, K. Ya. Zaslavskaya, P. A. Bely, A. V. Taganov, E. A. Rogozhina, K. N. Koryanova, E. S. Mishchenko, T. G. Bodrova, V. S. Shcherbakova
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2025-08-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
glp-1 agonist
liraglutide
peptide
metabolic syndrome
type 2 diabetes mellitus
obesity
weight loss
glucose
lipids
experiment
Online Access:https://www.pharmpharm.ru/jour/article/view/1688
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items